Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Multicenter, Multinational, Randomized, Placebo-Controlled Trial Evaluating Aztreonam Lysine For Inhalation in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa (AIR-CF4)

NCT00712166 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT00712166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00712166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Multicenter, Multinational, Randomized, Placebo-Controlled Trial Evaluating Aztreonam Lysine For Inhalation in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa (AIR-CF4)
Lead sponsor
Gilead Sciences
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2008
Completion date
August 31, 2009
Enrollment
160 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis, lung infection, pseudomonas aeruginosa